Dietary patterns among individuals with plasma cell disorders– opportunities for targeted interventions - Summary - MDSpire

Dietary patterns among individuals with plasma cell disorders– opportunities for targeted interventions

  • By

  • Kadiatou Traore

  • Francesca Castro

  • Andriy Derkach

  • Elan Gorshein

  • Edith Serrano

  • Alankrita Taneja

  • Jorge Arturo Hurtado Martínez

  • Alexander M. Lesokhin

  • Ana M. Sahagun Sanchez Aldana

  • Patricia Alejandra Flores Pérez

  • Saad Z. Usmani

  • Jenifer M. Ahlstrom

  • Torin Block

  • Jay R. Hydren

  • Cynthia A. Thomson

  • Urvi A. Shah

  • March 27, 2026

  • 0 min

Share

Objective:

To examine dietary patterns in patients with plasma cell disorders (PCDs) and their association with health outcomes.

Key Findings:
  • Average HEI score among participants was 69, higher than the general U.S. population average of 58.
  • HEI scores varied significantly by BMI, with lower scores in individuals classified as obese.
  • Higher education levels correlated with better dietary adherence, reflected in higher fiber intake and lower added sugar consumption.
  • Males reported higher caloric intake and lower vegetable and fiber consumption compared to females.
Interpretation:

Dietary quality, as measured by HEI scores, is associated with BMI and education level in patients with PCDs, suggesting potential for dietary interventions to improve health outcomes.

Limitations:
  • Study relied on self-reported dietary intake, which may introduce bias.
  • Limited racial/ethnic diversity among participants may affect generalizability.
Conclusion:

Improving dietary habits in patients with PCDs, particularly those with higher BMI and lower education levels, may enhance health outcomes and quality of life.

Original Source(s)

Dietary patterns among individuals with plasma cell disorders– opportunities for targeted interventions

  • by Kadiatou Traore, Francesca Castro, Andriy Derkach, Elan Gorshein, Edith Serrano, Alankrita Taneja, Jorge Arturo Hurtado Martínez, Alexander M. Lesokhin, Ana M. Sahagun Sanchez Aldana, Patricia Alejandra Flores Pérez, Saad Z. Usmani, Jenifer M. Ahlstrom, Torin Block, Jay R. Hydren, Cynthia A. Thomson, Urvi A. Shah

  • March 27, 2026

Related Content

Dana-Farber Team Develops Open-Access Predictive Tool to Improve Monitoring of Smoldering Multiple Myeloma

The tool, called PANGEA-SMM, outperforms existing predictive tools by more accurately determining when smoldering multiple myeloma is progressing and requires treatment. The free online tool can be used immediately to monitor patients.

  • by

  • March 24, 2026

  • 5 min
Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic